Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 4.06
-0.123 %
$ 283 M
Market Cap
-3.53
P/E
1. INTRINSIC VALUE
Balance Sheet
Health Catalyst, Inc.
| Current Assets | 466 M |
| Cash & Short-Term Investments | 392 M |
| Receivables | 57.2 M |
| Other Current Assets | 16.5 M |
| Non-Current Assets | 393 M |
| Long-Term Investments | 0 |
| PP&E | 41.5 M |
| Other Non-Current Assets | 352 M |
| Current Liabilities | 326 M |
| Accounts Payable | 11.4 M |
| Short-Term Debt | 235 M |
| Other Current Liabilities | 79.6 M |
| Non-Current Liabilities | 168 M |
| Long-Term Debt | 167 M |
| Other Non-Current Liabilities | 403 K |
EFFICIENCY
Earnings Waterfall
Health Catalyst, Inc.
| Revenue | 307 M |
| Cost Of Revenue | 166 M |
| Gross Profit | 141 M |
| Operating Expenses | 211 M |
| Operating Income | -69.8 M |
| Other Expenses | -304 K |
| Net Income | -69.5 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Health Catalyst, Inc.
| Net Income | -69.5 M |
| Depreciation & Amortization | 41.4 M |
| Capital Expenditures | -16.4 M |
| Stock-Based Compensation | 40.1 M |
| Change in Working Capital | -660 K |
| Others | -7.44 M |
| Free Cash Flow | -1.84 M |
Wall Street Analysts Price Targets
Health Catalyst, Inc.
Wall Street analysts predict an average 1-year price target for HCAT of $7.67 , with forecasts ranging from
a
low of
$5 to a high of $11 .
HCAT Lowest Price Target
Wall Street Target
5 USD
23.15%
HCAT Average Price Target
Wall Street Target
7.67 USD
88.83%
HCAT Highest Price Target
Wall Street Target
11 USD
170.94%
4. DIVIDEND
ANALYSIS
HCAT does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Health Catalyst, Inc.
Sold
0-3 MONTHS
45.2 K USD 2
3-6 MONTHS
226 K USD 3
6-9 MONTHS
837 K USD 6
9-12 MONTHS
256 K USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace
SALT LAKE CITY , July 1, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it is listing 10 AI-integrated data toolkits on Databricks Marketplace, an open marketplace for data, analytics and AI underpinned by the Databricks Data Intelligence Platform. These data toolkits, which can be securely shared via Delta Sharing, are purpose-built for some of healthcare's most pressing challenges and provide healthcare organizations with access to actionable, outcomes-focused resources that kickstart their measurable improvement journeys at no cost.
prnewswire.com
- 2 weeks ago
Health Catalyst (HCAT) Upgraded to Buy: Here's Why
Health Catalyst (HCAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
- 1 month ago
Health Catalyst: Ignite Platform Is A Growth Catalyst
I rate Health Catalyst a buy, driven by strong turnaround momentum and the transformative Ignite platform fueling faster growth and higher margins. Ignite's modular, lower-cost structure accelerates sales cycles, improves gross margins, and opens significant upsell opportunities within HCAT's large existing customer base. Recent financials show accelerating revenue growth and strong client additions, supporting management's FY25 guidance and signaling a potential inflection point for the business.
seekingalpha.com
- 1 month ago
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector 1x1 Conference, being held in Boston, on Tuesday, June 3, 2025. The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Tuesday, June 10, 2025.
globenewswire.com
- 2 months ago
Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Sarah James - Cantor Operator Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
seekingalpha.com
- 2 months ago
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
- 2 months ago
Health Catalyst (HCAT) Q1 Earnings Meet Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.
zacks.com
- 2 months ago
Health Catalyst Reports First Quarter 2025 Results
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. “For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric,” said Dan Burton, CEO of Health Catalyst.
globenewswire.com
- 2 months ago
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations
Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY , April 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation. The collaboration further builds on Health Catalyst's expertise with Microsoft Azure and Azure AI Foundry capabilities, equipping healthcare organizations with advanced AI solutions to accelerate time to value, enhance care delivery, and drive measurable, long-term improvement.
prnewswire.com
- 2 months ago
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
globenewswire.com
- 3 months ago
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025
AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.
zacks.com
- 3 months ago
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™
SALT LAKE CITY , April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices. Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver more with less.
prnewswire.com
- 3 months ago
8. Profile
Summary
Health Catalyst, Inc. HCAT
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 283 M
Dividend Yield
0.00%
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Contact
10897 South River Front Parkway, South Jordan, UT, 84095
https://www.healthcatalyst.com
IPO
Date
July 25, 2019
Employees
1500
Officers
Mr. Jeffrey P. Selander
Senior Vice President of International
Mr. Jason Alger
Chief Financial Officer
Mr. Kevin Freeman
Chief Commercial Officer
Ms. Amanda Flanders
Senior Vice President of Marketing & Communications
Mr. Benjamin Landry
General Counsel & Secretary of the Board
Mr. Kyle J. Salyers
Chief Strategy Officer & Senior Vice President of Corporate Development
Mr. Daniel D. Burton
Chief Executive Officer & Director
Mr. Daniel LeSueur
Chief Operating Officer
Mr. Dave Ross
Chief Technology Officer
Ms. Linda Llewelyn
Chief People Officer